No Detail Found!

Nkh477 inhibits proliferation and induces apoptosis in a panel of cancer cell lines.

Author(s)
Faris Q. Alenzi Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Saudi Arabia
Mohamed L. Salem Department of Surgery, Medical University of South Carolina Campus, Charleston, South Carolina
Waleed G. Tamimi King Abdulaziz Medical City, Riyadh, Saudi Arabia
Mahmoud Lotfy Department of Molecular and Cellular, Biotechnology Research Institute, Minufiya University, Egypt
Saad S. Al-Ghamdi College of Dentistry, King Saud University, Saudi Arabia
Laila Damanhouri College of Applied Medical Sciences, King Abdulaziz University, Jedda, Saudi Arabia
Talat Bukhari Department of Surgery, Hammersmith Campus, Imperial College of Medicine, London, UK
Richard Khwyse Department of Surgery, Hammersmith Campus, Imperial College of Medicine, London, UK
Abstract
Background and Objectives: The anti-proliferative effects of cAMP in cancer cells may be regulated by the adenylyl-cyclase-V isoform. As Colforsin Daropate (NKH477) is more selective for this isoform, we hypothesized that this water soluble compound may promise utility as an oral anti-tumour agent. Materials and Methods: Using separate cancer cell lines (MCF7, HT29, A431, WiDr, RKO, A375, H630, Du145, SW480 and SW620), we studied the effects of NKH477 on cell proliferation, cell viability and apoptosis. Results: NKH477 induced >70% inhibition of proliferation in all cancer cell lines tested. NKH477 induced a dose-dependent apoptosis causing G1 arrest and priming cells to die. Conclusions: NKH477 treatment on the tested cell lines inhibited proliferation and induced apoptosis. Thus, NKH477 shows early promise as an oral anti-cancer agent
Publication Details
Page(s) 182-187
DOI DOI not available
Published Journal: Journal of Postgraduate Medical Institute, Volume: 24, Issue: 3, Year: 2010

Request the full text from PASTIC

0

Citations

0

Downloads

48

Views